KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GOSS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very red day for Gossamer Bio Inc. stock price after a -5.41% fall in the Thursday trading session
(Updated on Apr 25, 2024)

Sell candidate since Mar 26, 2024 Loss -45.53% PDF

The Gossamer Bio Inc. stock price fell by -5.41% on the last day (Thursday, 25th Apr 2024) from $0.708 to $0.670. It has now fallen 10 days in a row. During the last trading day the stock fluctuated 9.46% from a day low at $0.633 to a day high of $0.693. The price has fallen in 10 of the last 10 days and is down by -30.75% for this period. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $1.66 million.

Given the current short-term trend, the stock is expected to fall -3.39% during the next 3 months and, with a 90% probability hold a price between $0.647 and $1.43 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GOSS Signals & Forecast

There are few to no technical positive signals at the moment. The Gossamer Bio Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.753 and $1.11. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 06, 2024, and so far it has fallen -55.63%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Gossamer Bio Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0599 between high and low, or 9.46%. For the last week, the stock has had daily average volatility of 12.53%.

Gossamer Bio Inc. is oversold on RSI14 (11). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GOSS) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Gossamer Bio Inc. to open at $0.666, and during the day (based on 14 day Average True Range), to move between $0.579 and $0.761, which gives a possible trading interval of +/-$0.0909 (+/-13.57%) up or down from last closing price. If Gossamer Bio Inc. takes out the full calculated possible swing range there will be an estimated 27.14% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.738, some $0.0676 (10.09%) from the current price of $0.670, our system finds the risk reward not very attractive.

Is Gossamer Bio Inc. stock A Buy?

Gossamer Bio Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.009 Sell Candidate Unchanged

Predicted Opening Price for Gossamer Bio Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$0.666 ( 0.672%) $0.670

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GOSS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.725 8.27 %
R2 0.703 4.85 %
R1 0.688 2.74 %
Current price: 0.670
Support S1 0.643 -4.09 %
S2 0.628 -6.20 %
S3 0.606 -9.61 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.82 22.39 %
R2 0.743 10.90 %
R1 0.738 10.09 %
Current price 0.670
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Gossamer Bio Inc. Stock and on which exchange is it traded?
The symbol for Gossamer Bio Inc. is GOSS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Gossamer Bio Inc. Stock?
Gossamer Bio Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Gossamer Bio Inc. Stock?
Gossamer Bio Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Gossamer Bio Inc. Stock.

What's the current price of Gossamer Bio Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Gossamer Bio Inc. (GOSS) share was $0.670.

What is the 52-week high and low for Gossamer Bio Inc. Stock?
The 52-week high for Gossamer Bio Inc. Stock is $1.88 and the 52-week low is $0.453.

What is the market capitalization of Gossamer Bio Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Gossamer Bio Inc. is 151.14M.

When is the next earnings date for Gossamer Bio Inc.?
The upcoming earnings date for Gossamer Bio Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Gossamer Bio Inc.

Gossamer Bio. Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hy... GOSS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT